• SR 11302: Applied Workflows for AP-1 Transcription Factor In

  2026-06-17

  SR 11302 stands out as a selective AP-1 transcription factor inhibitor, enabling precise blockade of tumorigenic pathways with minimal off-target activity. This article translates recent research and hands-on protocol expertise into actionable steps for maximizing reproducibility and impact in cancer studies.

• Merimepodib (VX-497): IMPDH Inhibition for Host-Directed Ant

  2026-06-17

  Explore the unique host-directed antiviral and immunosuppressive mechanisms of Merimepodib (VX-497), a selective IMPDH inhibitor. This article unveils advanced applications and deep mechanistic insights, extending beyond conventional reviews.

• Pertussis Toxin: Advanced Immune Modulation for TH17 Researc

  2026-06-16

  Explore how high-purity Pertussis toxin enables translational researchers to dissect cAMP-driven immune modulation, particularly TH17 differentiation and autoimmunity, while offering strategic guidance for experimental rigor and clinical innovation. This article bridges mechanistic insight with workflow optimization, referencing Helicase A's role in TH17 lineage and highlighting APExBIO’s competitive advantage.

• Applied Workflows with EZ Cap EGFP mRNA 5-moUTP for Gene Exp

  2026-06-16

  EZ Cap™ EGFP mRNA (5-moUTP) delivers superior stability and translation efficiency for gene expression and imaging assays. This guide covers experimental workflows, troubleshooting, and how recent mRNA engineering advances directly inform best practices.

• Merimepodib (VX-497): Reliable IMPDH Inhibition for Reproduc

  2026-06-15

  This article addresses common laboratory challenges in cell viability, proliferation, and antiviral assays, providing scenario-driven guidance on the use of Merimepodib (VX-497), SKU B1112. By integrating evidence-based answers and practical workflow insights, it demonstrates how this APExBIO compound enables reproducible and interpretable results for biomedical researchers.

• Tamsulosin: Applied Protocols for Urological Research Succes

  2026-06-15

  Tamsulosin (R)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide, supplied by APExBIO, is the gold standard for precise α₁A-adrenergic receptor antagonism in urological and GPCR research. This detailed guide delivers optimized workflows, data-driven troubleshooting, and practical insight into leveraging Tamsulosin’s selectivity and solubility for experimental reproducibility.

• Zolmitriptan as a 5-HT1B Receptor Agonist: Advanced Workflow

  2026-06-14

  Leverage Zolmitriptan’s high selectivity for 5-HT1B/1D/1F receptors to model migraine and cluster headache mechanisms with confidence. This guide details protocol optimizations, experimental troubleshooting, and the latest translational insights for deploying this APExBIO-supplied compound in serotonin receptor pharmacology research.

• Sodium Orthovanadate: Precision Phosphorylation State Preser

  2026-06-13

  Sodium Orthovanadate (Na3VO4) is the gold-standard tool for preserving tyrosine phosphorylation in cell signaling and kinase assays, enabling robust investigation of phosphorylation-dependent pathways. APExBIO’s high-purity Na3VO4 stands out for its reversible inhibition and compatibility with diverse experimental workflows, supporting reproducibility and specificity in metabolic and signaling research.

• Deferiprone in Iron Stress Research: Protocols & Workflow Ad

  2026-06-12

  Deferiprone (3-hydroxy-1,2-dimethylpyridin-4-one) enables precise modulation of cellular iron, unlocking reproducible workflows for apoptosis induction, cancer biology, and neurovascular models. This article delivers actionable protocols, troubleshooting insights, and data-driven guidance for leveraging Deferiprone in advanced bench research.

• SIS3 (Smad3 Inhibitor): Mechanisms and Benchmarks in Fibrosi

  2026-06-12

  SIS3 is a potent and selective Smad3 inhibitor that enables precise modulation of the TGF-β pathway in fibrosis and nephropathy models. Its specificity for Smad3 phosphorylation, with minimal off-target effects, positions it as a critical tool in preclinical research. Benchmarked efficacy includes dose-dependent suppression of fibrotic signaling in vitro and in vivo.

• Deferiprone in Tumor Iron Metabolism: Precision Tools for Ir

  2026-06-11

  Explore how Deferiprone enables advanced studies of iron metabolism and apoptosis induction in cancer biology. This article offers a mechanistic deep dive, protocol insights, and practical research applications beyond existing guides.

• Lycopene Mitigates DON-Induced Gut Barrier Injury via ERK Pa

  2026-06-11

  This study presents novel evidence that lycopene protects intestinal epithelial cells from deoxynivalenol (DON)-induced barrier dysfunction and inflammation by targeting the ERK pathway. These findings clarify the mechanistic basis for dietary antioxidant intervention against mycotoxin-induced gut injury and highlight the ERK signaling axis as a therapeutic target.

• VX-765 and VRT-043198: Precision Caspase-1 Inhibition in Mod

  2026-06-10

  Explore how VX-765, a potent caspase-1 inhibitor, advances precision inflammation and cell death studies. This article uniquely connects functional genomic screening innovations with practical assay design for selective cytokine modulation.

• Reliable Cell Assays Using CK2 and ERK8 Inhibitor (SKU B7464

  2026-06-10

  This article explores how CK2 and ERK8 inhibitor (SKU B7464), a high-purity small molecule inhibitor, addresses common challenges in cell viability and kinase signaling assays. Scenario-driven Q&A blocks provide evidence-based strategies for reproducibility and data quality, highlighting how this research-use-only compound from APExBIO supports rigorous biochemical research.

• Neuroligin 1 Loss Drives Repetitive Behaviors via D2-MSN Hyp

  2026-06-09

  This study uncovers how Neuroligin 1 deficiency in striatal D2 receptor-expressing medium spiny neurons (D2-MSNs) leads to autistic-like repetitive behaviors through PKC overactivation and neuronal hyperexcitability. These findings clarify cellular mechanisms underlying restricted and repetitive behaviors in autism spectrum disorder, offering new molecular intervention points for translational neuroscience.

447 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page